Has the anti-aging pill been found?

It sounds very attractive, only one pill separates us from the inevitable - age.

Thus, scientists from the Netherlands and Singapore researched the effects of the drug rapamycin and its possibilities in the fight against cell death, which ultimately leads us to old age.

They researched and cross-referenced data from more than 18.000 scientific articles and 19 studies that looked at the drug to determine what physiological changes and prevention of age-related diseases occur when rapamycin is injected.

A man who wants to live forever

By the way, this is not a new drug that has just appeared on the market and is sold with these instructions - injections three times a day if you don't want to get old. Rapamycin has been known in clinical practice for years and acts as an immunosuppressant. It is used after organ transplantation because it prevents their rejection, and coronary stents are also coated with it before installation.

The whole public found out about it since the eccentric billionaire Brian Johnson started injecting it, who also made a documentary about it. It can even be viewed on Netflix, under the title Don't Die: The Man Who Wants to Live Forever.

What have scientists found?

For those who still care more about what the doctors say than the semi-lucid rich man, you should know that scientists have discovered that rapamycin really does change something and that it has something to do with aging, but only with certain diseases that follow the lifespan.

"Rapamycin and its derivatives improved age-related physiological parameters in the immune and cardiovascular systems of healthy individuals or individuals with age-related diseases," the article says, which would mean the drug may protect the heart and immunity from deterioration.

However, no significant effects on the endocrine, muscular or neurological system were found, i.e. it is possible that the drug does not act to prevent the aging of nerves, muscles, glands and hormones. Also, the effects of rapamycin or its derivatives on the respiratory, digestive, renal and reproductive systems have not been evaluated.

"No serious adverse effects attributed to rapamycin and its derivatives have been reported in healthy individuals. However, there have been increased infections and increases in cholesterol and triglycerides in individuals with age-related diseases. Future studies should evaluate the remaining untested systems and test the effects of long-term exposure to rapamycin and its derivatives," it added.